Prelude Capital Management’s Kezar Life Sciences KZR Stock Holding History

Prelude Capital Management’s Portfolio KZR Stock Details KZR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$333K	Buy
2024 Q3	–	Sell
2024 Q2	$11.1K	Sell
2024 Q1	$90.9K	Buy
2023 Q3	–	Sell
2023 Q2	$88.7K	Buy
2023 Q1	$51.1K	Buy